We share weekly commentaries with investors on stocks in our strategies that have appreciated or dropped more than 15% in a day during the course of the week. We hope you find this commentary useful.
|Ginkgo Bioworks (DNA)|
|+20%||Ginkgo Bioworks (DNA), a synthetic biology platform company that went public in September, appreciated roughly 20% on Tuesday. Following the publication of what we believe to be a baseless short report, Ginkgo’s shares had been under significant pressure. Now, after digesting and dismissing many of the report’s claims, investors seem to be taking advantage of the buying opportunity it created.|
注: 9月份上市的合成生物学平台公司 Ginkgo Bioworks（DNA）周二升值了大约20%。在我们认为是毫无根据的空头报告发表后，银杏的股价曾受到很大压力。现在，在消化并否定了该报告的许多说法之后，投资者似乎正在利用它所创造的购买机会。
|-26%||Snap (SNAP) declined 26% today after announcing third quarter earnings that missed revenue estimates. Management blamed iOS privacy changes, global supply chain interruptions, and labor shortages, all of which they believe will persist into the fourth quarter. Despite the revenue miss, Snap grew daily active users by 23% year-over-year to 306 million, marking the fourth consecutive quarter of 20%+ growth.|